Shanghai INT Medical Instruments Past Earnings Performance
Past criteria checks 3/6
Shanghai INT Medical Instruments has been growing earnings at an average annual rate of 9.7%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 24.9% per year. Shanghai INT Medical Instruments's return on equity is 10.2%, and it has net margins of 20.8%.
Key information
9.7%
Earnings growth rate
6.6%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 24.9% |
| Return on equity | 10.2% |
| Net Margin | 20.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital
Jul 14
Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year
May 17Returns On Capital At Shanghai Kindly Medical Instruments (HKG:1501) Paint A Concerning Picture
Nov 26Shanghai Kindly Medical Instruments (HKG:1501) Is Reinvesting At Lower Rates Of Return
Aug 16Some Investors May Be Worried About Shanghai Kindly Medical Instruments' (HKG:1501) Returns On Capital
Apr 24Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.'s (HKG:1501) 1.0% Yield
Apr 05What Is The Ownership Structure Like For Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?
Mar 15Declining Stock and Decent Financials: Is The Market Wrong About Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?
Jan 28Here's Why I Think Shanghai Kindly Medical Instruments (HKG:1501) Might Deserve Your Attention Today
Dec 28
Is Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) Popular Amongst Insiders?
Dec 02Revenue & Expenses Breakdown
How Shanghai INT Medical Instruments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 805 | 167 | 186 | 132 |
| 31 Mar 24 | 779 | 160 | 177 | 129 |
| 31 Dec 23 | 753 | 152 | 167 | 126 |
| 30 Sep 23 | 727 | 155 | 154 | 126 |
| 30 Jun 23 | 700 | 159 | 140 | 126 |
| 31 Mar 23 | 643 | 144 | 131 | 113 |
| 31 Dec 22 | 586 | 130 | 122 | 100 |
| 30 Sep 22 | 548 | 137 | 109 | 91 |
| 30 Jun 22 | 509 | 143 | 96 | 83 |
| 31 Mar 22 | 487 | 143 | 88 | 86 |
| 31 Dec 21 | 465 | 143 | 80 | 90 |
| 30 Sep 21 | 416 | 124 | 70 | 85 |
| 30 Jun 21 | 367 | 105 | 60 | 79 |
| 31 Mar 21 | 363 | 113 | 59 | 72 |
| 31 Dec 20 | 358 | 121 | 57 | 65 |
| 30 Sep 20 | 341 | 121 | 63 | 56 |
| 30 Jun 20 | 323 | 120 | 69 | 48 |
| 31 Mar 20 | 305 | 110 | 63 | 40 |
| 31 Dec 19 | 286 | 100 | 58 | 31 |
| 31 Dec 18 | 203 | 58 | 38 | 22 |
| 31 Dec 17 | 138 | 41 | 19 | 13 |
| 31 Dec 16 | 106 | 34 | 16 | 11 |
Quality Earnings: 1501 has high quality earnings.
Growing Profit Margin: 1501's current net profit margins (20.8%) are lower than last year (22.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1501's earnings have grown by 9.7% per year over the past 5 years.
Accelerating Growth: 1501's earnings growth over the past year (5.3%) is below its 5-year average (9.7% per year).
Earnings vs Industry: 1501 earnings growth over the past year (5.3%) exceeded the Medical Equipment industry -4.3%.
Return on Equity
High ROE: 1501's Return on Equity (10.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 12:10 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai INT Medical Instruments Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | CMB International Securities Limited |
| Yu Wu | CMB International Securities Limited |
| Xin Qiu Lin | Guoyuan Securities (HK) Ltd |